Corcept Therapeutics | CORT - سود ناخالص در فروش





سود ناخالص در فروش تغییر دادن تاریخ
Acadia Pharmaceuticals USD 257.76M 778K 2025-12
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
ANI Pharmaceuticals USD 124.18M 12.39M 2025-12
Ardelyx USD 114.37M 8.02M 2025-12
Assertio Holdings USD 22.24M 970K 2024-06
Aurora Cannabis CAD 46.62M 14.33M 2025-12
BioMarin Pharmaceutical USD 713.01M 81.81M 2025-12
Bristol-Myers Squibb USD 8.79B 110M 2025-09
Canopy Growth CAD 21.47M 434K 2025-12
Corcept Therapeutics USD 199.58M 3.46M 2025-12
Eli Lilly USD 14.59B 1.48B 2025-09
Esperion Therapeutics USD 140.59M 94.57M 2025-12
J&J USD 16.6B 118M 2025-12
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Lexicon Pharmaceuticals USD 5.29M 8.88M 2025-12
Merck USD 13.42B 431M 2025-09
Nektar Therapeutics USD 21.81M 8.06M 2025-12
Novartis USD 10.25B 570M 2025-12
Novartis USD 10.82B 694M 2025-09
Omeros USD -33.16M 18.52M 2024-06
Pacira USD 142.25M 11.34M 2025-12
Pfizer USD 3.54B 7.61B 2025-09
Supernus Pharmaceuticals USD 164.04M 15.23M 2025-12
TG Therapeutics USD 154.43M 20.81M 2025-12